Newcastle medtech begins £11m expansion to mass-manufacture diagnostic device

A North East based life sciences company is investing millions of pounds into scaling up operations to mass manufacture its diagnostic products.

QuantuMDx has announced today that it is investing over £11m to scale up production to mass manufacture its flagship diagnostic device Q-POC and disposable test cassette.

Q-POC is a portable PCR device offering rapid molecular diagnostic testing at the point of care, with results in approximately 30 minutes, and comprising a sample collection kit, single-use test cassette and analyser.

Jonathan O’Halloran, chief executive at QuantuMDx, commented: “We have developed the Q-POC over the past 10 years and created one of the fastest, most accurate and powerful PCR diagnostic devices on the market, and at the right time to be able to respond to the pandemic.

“We’re delighted to be working with Univac, RD Support and fellow British partners, Cogent and CDP to support the international response to COVID-19 testing.

“Scaling-up was always going to be a challenge, especially during a global pandemic, but with the commitment, focus and dedication of everyone involved with QuantuMDx and our partners, we’ll soon be able to introduce our rapid, point of care diagnostic solution to benefit frontline health workers, across the globe.

“With the large manufacturing scale that we have achieved, QuantuMDx is poised to become an important player in the molecular diagnostics industry.”

Want your business, product or service to be seen regionally and nationally? Bdaily helps you get your story in front of the right audience, every day. Find out how Bdaily can help →

Join more than 55,000 subscribers by signing up to our daily bulletin each morning here.